Switzerland · 
Who invested in NXI Therapeutics?
NXI Therapeutics's investors include JFG Life Sciences Foundation, K Fund, Venture Kick, Kickfund and BaseLaunch. JFG Life Sciences Foundation led its latest round.
Switzerland · Pre-seed startup
Who invested in NXI Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.0Mraised across 1 round since 2024, from 2 sources
- Latest round
- Pre-seed, $4.0MJun 2024
- Led by
- JFG Life Sciences Foundation
- Investors
- 5 (1 led)
The rounds
- Jun 2024Pre-seed$4.0M
Reported by Firms' own news pages and 1 other
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists NXI Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about NXI Therapeutics
How much has NXI Therapeutics raised?
NXI Therapeutics has raised $4.0M across 1 round since 2024.
When did NXI Therapeutics last raise?
NXI Therapeutics's most recent round was a Pre-seed of $4.0M in Jun 2024, led by JFG Life Sciences Foundation.
What was NXI Therapeutics's biggest round?
Its most recent round, $4.0M in Jun 2024, is also its largest on record.
Who backed NXI Therapeutics first?
NXI Therapeutics's first round on record, in Jun 2024, was backed by JFG Life Sciences Foundation, K Fund and Venture Kick and 2 others.
What stage is NXI Therapeutics at?
NXI Therapeutics's latest named round is a Pre-seed, in Jun 2024.
Where is NXI Therapeutics based?
NXI Therapeutics is based in Switzerland.
Who led NXI Therapeutics's rounds?
JFG Life Sciences Foundation led the Pre-seed in 2024.
Companies like NXI Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.